A comprehensive review of Alport syndrome: definition, pathophysiology, clinical manifestations, and diagnostic considerations
10.23876/j.krcp.24.065
- Author:
Eunjeong KANG
;
Byung Hwa PARK
;
Hajeong LEE
;
Hee Gyung KANG
;
Ji Hyun KIM
;
Ye Na KIM
;
Yeonsoon JUNG
;
Hark RIM
;
Ho Sik SHIN
- Publication Type:Review Article
- From:Kidney Research and Clinical Practice
2025;44(4):566-575
- CountryRepublic of Korea
- Language:English
-
Abstract:
Alport syndrome, a rare genetic disorder affecting around 1 in 50,000 individuals, primarily presents as microscopic hematuria and chronic kidney disease (CKD) with associated extrarenal complications. The Alport syndrome results from mutations in COL4A3, COL4A4, and COL4A5 genes, disrupting the formation of the α3–α4–α5 chain in the collagen IV network. The etiology involves X chromosome- related, autosomal dominant, autosomal recessive, and digenic inheritance patterns. The disease primarily manifests as kidney involvement, featuring persistent hematuria, proteinuria, and a progressive decline in renal function. Hearing loss, ocular abnormalities, and extrarenal manifestations further contribute to its complexity. Genotype-phenotype correlations are relatively evident, with distinct presentations in X-linked, autosomal recessive, and autosomal dominant cases. Diagnosis relies on urinalysis, histologic examination, and genetic testing with advancements in next-generation sequencing aiding identification. Although no specific treatment exists, early diagnosis improves outcomes, emphasizing the importance of genetic testing for prognosis and familial screening. The purpose of this review is to advance knowledge and enhance understanding of Alport syndrome.
